Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Botox Adds Therapeutic Indication For Idiopathic Overactive Bladder

Related Content

NICE Clears Botox For Chronic Migraine, With Therapy “Stopping Rules”

Jun 27 2012

Astellas Expands Its Presence In Urology With <em>Myrbetriq</em> Approval

Jul 02 2012

Related Companies

Allergan plc

Astellas Pharma, Inc.

Additional Topics

Launches BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window